60.9 F
New York
Thursday, October 1, 2020

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is Gaining Momentum on Earnings Catalyst

Must read

Is Now the Time to Invest in Mattel Inc. (NASDAQ:MAT)?

Mattel Inc. (MAT) shares are trading at higher $11.70 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Kadmon Holdings Inc. (NYSE:KDMN) is Gaining Momentum on Earnings Catalyst

Kadmon Holdings Inc. (KDMN) shares are trading at higher $3.92 and the avg recommendation for the stock is Strong Buy. To add more color...

Aflac Incorporated (NYSE:AFL) Finding Strong Support

Aflac Incorporated (AFL) shares are trading at higher $36.35 and the avg recommendation for the stock is Hold, while the current analyst price target...

Investor Confidence is Falling for Apple Hospitality REIT Inc. (NYSE:APLE)

Apple Hospitality REIT Inc. (APLE) shares are trading at lower $9.61 and the avg recommendation for the stock is Moderate Buy, while the current...

The Aurinia Pharmaceuticals Inc. (AUPH) shares are trading at higher $14.71 and the avg recommendation for the stock is Strong Buy. while the current analyst price target stands at $11.92.

To add more color to this target, the company’s high over the last year is $21.93 and the low is $3.52. Over the last 52 weeks, AUPH is down -32.92% while the S&P 500 is up 0.92%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, AUPH reported a profit of $25.3 million. Aurinia Pharmaceuticals Inc. also saw revenues increase to $30000.0. In addition, AUPH has free cash flow of -$22.77 million as of 03-2020. The company’s EBITDA came in at -$24.9 million which compares well with its peers.

Find out when AUPH reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. AUPH has a short ratio of 4.32 and outstanding shares of 112.63M.

Company Outlook

AUPH has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.03 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.30. Aurinia Pharmaceuticals Inc. AUPH also noted assets of $314.97 million at the end of the last quarter. Investors should also keep an eye on sector updates as AUPH has historically followed its peers on positive news.

All told, Aurinia Pharmaceuticals Inc. AUPH has strung together solid data and demonstrated underlying fundamentals. At its current valuation, AUPH represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Aurinia Pharmaceuticals Inc. AUPH is now commanding a market cap of 1.66B and a float of 78.71M. AUPH is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of AUPH stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in AUPH, either long or short, and we have not been compensated for this article.

Latest article

Investor Confidence is Rising for Remark Holdings Inc. (NASDAQ:MARK)

Remark Holdings Inc. (MARK) shares are trading at higher $1.17. To add more color to this target, the company’s high over the last year...

Hilton Worldwide Holdings Inc. (NYSE:HLT) is Gaining Momentum on Earnings Catalyst

Hilton Worldwide Holdings Inc. (HLT) shares are trading at lower $85.32 and the avg recommendation for the stock is Moderate Buy, while the current...

The Rejuvenation of ViewRay Inc. (NASDAQ:VRAY)

ViewRay Inc. (VRAY) shares are trading at higher $3.50 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Verastem Inc. (NASDAQ:VSTM) Recent Earnings Shows Major Concern

Verastem Inc. (VSTM) shares are trading at lower $1.21 and the avg recommendation for the stock is Moderate Buy. To add more color to...

The Unprecedented Rise of KKR & Co. Inc. (NYSE:KKR)

KKR & Co. Inc. (KKR) shares are trading at higher $34.34 and the avg recommendation for the stock is Moderate Buy, while the current...